DNA Replication Licensing Proteins for Early Detection of Lung Cancer

Document Type: Research Articles

Authors

1 Division of Pathology, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram, India.

2 Respiratory Medicine, Medical College,Thiruvananthapuram, India.

3 Division of Cancer Research, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram, India.

4 Division of Cancer Epidemiology and Biostatistics, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram, India.

5 Surgical Oncology, Regional Cancer Centre, Medical College Campus, Thiruvananthapuram, India.

Abstract

 
Background: To identify and characterize malignant and premalignant cells in sputum and matched tissue samples with reference to expression of minichromosome maintenance proteins (MCM2, MCM5) and cell division cycle protein 6 (CDC 6) and to assess their potential as biomarkers of premalignant and malignant lesions of the lung and associations with clinicopathological features. Methods: Expression of MCM2, MCM5 and 6 proteins in sputum samples and corresponding tissues was assessed by immunocytochemistry, and correlated with histological findings. Results: For characterization of malignant, metaplastic or dysplastic cells, CDC6 protein had the highest sensitivity of 87.7%. All the three markers together had a sensitivity of 94.4%. Furthermore these proteins could be employed to assess the proliferative potential of precancerous or atypical cells, as overexpression increasing with the stage of disease and degree of metastasis. Conclusion: The assessed markers can be utilized in routine cytopathology laboratories to supplement conventional morphological evaluation so that the sensitivity of sputum cytology can be enhanced. Potential applications in predicting the clinical behavior of lung lesions and predicting prognosis and survival deserve further attention.

Keywords

Main Subjects